Axena Health: Revolutionizing Female Pelvic Health

Axena Health, a trailblazing medical device company, has secured a whopping $9.4 million in additional funding to propel its mission of transforming female pelvic health. Led by Cross-Border Impact Ventures (CBIV) and supported by existing investors AXA IM Alts, KOFA Healthcare, and Avestria Ventures, Axena Health is on a relentless quest to provide innovative solutions for women worldwide. Donna Parr, a powerhouse in the investment world, is now a key player on Axena Health's board of directors, steering the company towards unprecedented growth. With a focus on the US market, Axena Health is laser-focused on expanding the reach of its groundbreaking Leva Pelvic Health System, a game-changing at-home treatment for urinary incontinence and chronic fecal incontinence in women. But Axena Health's ambitions don't stop there - they are committed to revolutionizing female pelvic health in low- and middle-income countries, ensuring that women everywhere have access to life-changing treatments. Pelvic floor disorders are a global issue, impacting women of all walks of life. Axena Health's Leva Pelvic Health System offers a beacon of hope, providing a non-invasive, drug-free solution that empowers women to take control of their health and well-being. With cutting-edge technology that allows for real-time monitoring and personalized treatment plans, Axena Health is at the forefront of a new era in female pelvic health. The road ahead may be challenging, but with the unwavering support of investors like CBIV and AXA IM Alts, Axena Health is poised to make a lasting impact on the lives of women around the world. Watch this space - the future of female pelvic health is here, and Axena Health is leading the charge.